Developing anti-CD19 antibody-based combinations in lymphoma

被引：2
|
作者：
Kuruvilla, John [1 ]
机构：
[1] Princess Margaret Canc Ctr, Div Med Oncol & Hematol, Toronto, ON M5G 2M9, Canada
来源：
LANCET ONCOLOGY | 2020年 / 21卷 / 07期
关键词：
D O I：
10.1016/S1470-2045(20)30275-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：870 / 872
页数：3
相关论文
共 50 条
  • [1] THE ANTITUMOR-ACTIVITY OF AN ANTI-CD22 IMMUNOTOXIN IN SCID MICE WITH DISSEMINATED DAUDI LYMPHOMA IS ENHANCED BY EITHER AN ANTI-CD19 ANTIBODY OR AN ANTI-CD19 IMMUNOTOXIN
    GHETIE, MA
    TUCKER, K
    RICHARDSON, J
    UHR, JW
    VITETTA, ES
    BLOOD, 1992, 80 (09) : 2315 - 2320
  • [2] Bi-213 labeled anti-CD19 antibody construct for lymphoma therapy.
    Ma, D
    McDevitt, MR
    Barendswaard, E
    Curcio, MJ
    Lai, L
    Brechbiel, MW
    Finn, RD
    Scheinberg, DA
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (05) : 106P - 107P
  • [3] SGN-CD19A: A novel Anti-CD19 antibody drug conjugate
    Albertson, Tina M.
    Sandalic, Lali
    Zhao, Baiteng
    Kostic, Ana
    Law, Che-Leung
    CANCER RESEARCH, 2014, 74 (19)
  • [4] Anti-CD19 Monoclonal Antibodies: a New Approach to Lymphoma Therapy
    Naddafi, Fatemeh
    Davami, Fatemeh
    INTERNATIONAL JOURNAL OF MOLECULAR AND CELLULAR MEDICINE, 2015, 4 (03) : 143 - 151
  • [5] Anti-CD30 antibody-based therapy
    Koon, HB
    Junghans, RP
    CURRENT OPINION IN ONCOLOGY, 2000, 12 (06) : 588 - 593
  • [6] INITIAL EXPERIENCE WITH TREATMENT OF HUMAN B-CELL LYMPHOMA WITH ANTI-CD19 MONOCLONAL-ANTIBODY
    HEKMAN, A
    HONSELAAR, A
    VUIST, WMJ
    SEIN, JJ
    RODENHUIS, S
    HUININK, WWT
    SOMERS, R
    RUMKE, P
    MELIEF, CJM
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1991, 32 (06) : 364 - 372
  • [7] XmAb™ Fe engineered anti-CD19 monoclonal antibody with enhanced in vitro efficacy against lymphoma and leukemia
    Zhukovsky, Eugene
    Chu, Seung
    Bernett, Matthew
    Karki, Sher
    Richards, John
    Pong, Erik
    Peipp, Matthias
    Repp, Roland
    Desjarlais, John
    BLOOD, 2007, 110 (11) : 690A - 691A
  • [8] Anti-CD19 antibody-drug conjugate therapy in B cell non-Hodgkin lymphoma
    Saito, Chieko
    Bi, Chengfeng
    Fu, Kai
    CANCER RESEARCH, 2023, 83 (07)
  • [9] Development of novel anti-CD19 antibody-drug conjugates for B-cell lymphoma treatment
    Li, Zhuanglin
    Wang, Mingxue
    Yao, Xuejing
    Li, Huanzhao
    Li, Shenjun
    Liu, Lina
    Yu, Deling
    Li, Xue
    Fang, Jianmin
    Huang, Changjiang
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2018, 62 : 299 - 308
  • [10] Anti-CD19 antibody cotreatment enhances serial killing activity of anti-CD19 CAR-T/-NK cells and reduces trogocytosis
    Koh, Seung Kwon
    Kim, Hyojin
    Han, Bohwa
    Jo, Hantae
    Doh, Junsang
    Park, Jeehun
    Ha Nguyen, Minh
    Kim, Hyun-Young
    Kim, Haneul
    Lee, Seung-Hwan
    Kim, Chan Hyuk
    Cho, Duck
    BLOOD, 2025, 145 (09) : 956 - 969
12345